TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)

Taiwan · Delayed Price · Currency is TWD

10.55

-0.35 (-3.21%)

Apr 17, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Development, Research and Sales of New Drugs	259.42M	149.15M	119.15M	36.23M	1.29B
Development, Research and Sales of New Drugs Growth	73.93%	25.18%	228.87%	-97.20%	5426.95%
The Others	58.00K	1.50M	3.99M	-	-
The Others Growth	-96.14%	-62.34%	-	-	-
Total	259.47M	150.65M	123.13M	36.23M	1.29B
Total Growth	72.24%	22.35%	239.87%	-97.20%	5426.95%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan	36.32M	38.78M	30.57M	21.03M	8.14M
Taiwan Growth	-6.34%	26.84%	45.36%	158.45%	32.31%
Mainland China	190.07M	111.88M	92.57M	-	1.24B
Mainland China Growth	69.89%	20.86%	-	-	8953.58%
India	31.56M	-	-	-	-
Vietnam	1.53M	-	-	-	-
Russia	-	-	-	15.20M	-
South Korea	-	-	-	-	44.23M
Total	259.47M	150.65M	123.13M	36.23M	1.29B
Total Growth	72.24%	22.35%	239.87%	-97.20%	5426.95%

Source: S&P Global Market Intelligence.